Improving health and medication use for aging World Trade Center responders
Promoting healthy aging and improving medication use in World Trade Center general responders
This study is looking at ways to help older responders from the World Trade Center stay healthy as they age, focusing on improving their medication management and overall well-being.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10995103 on NIH RePORTER |
What this research studies
This research focuses on the health needs of aging World Trade Center responders, particularly those who are now at risk for conditions related to aging. It aims to implement evidence-based interventions that promote healthy aging and improve medication management among this population. The study will explore how to effectively integrate these interventions into the existing WTC Health Program to better serve the responders as they age. By addressing frailty and medication use, the research seeks to enhance the overall health outcomes for these individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are World Trade Center responders who are aged 65 and over or approaching this age and may be experiencing frailty or medication management issues.
Not a fit: Patients who are not World Trade Center responders or those who are younger than 65 may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health and quality of life for aging World Trade Center responders.
How similar studies have performed: Previous research has shown success in implementing healthy aging interventions in similar populations, indicating a promising approach for this study.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Hung, William W.,mph, Md — Icahn School of Medicine at Mount Sinai
- Study coordinator: Hung, William W.,mph, Md
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.